Year archive

Saniona — 2021 filings

All 41 regulatory filings released by Saniona (SANION) in 2021, sourced directly from the official regulator.

41 Filings

2021 Period

2021 filings (41)

Filing	Released	Lang
Saniona AB’s Nomination Committee for the Annual General Meeting 2022 Regulatory Filings	2021-11-25	English
Saniona AB:s valberedning inför årsstämman 2022 Governance Information	2021-11-25	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report 9M 2021	2021-11-18	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report 9M 2021	2021-11-18	English
Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-09-16	English
Kommuniké från extra bolagsstämma den 16 september 2021 i Saniona AB Declaration of Voting Results & Voting Rights Announcements	2021-09-16	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report H1 2021	2021-08-26	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report H1 2021	2021-08-26	English
Notice of Saniona AB extraordinary shareholders’ meeting to elect new member of the board of directors Proxy Solicitation & Information Statement	2021-08-20	English
Kallelse till extra bolagsstämma i Saniona AB för val av ny styrelseledamot Proxy Solicitation & Information Statement	2021-08-20	Swedish
Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity Regulatory Filings	2021-07-26	English
Saniona får särläkemedelsklassning av FDA för Tesomet mot hypotalamisk fetma Regulatory Filings	2021-07-26	Swedish
Major Shareholding Notification 2021 Major Shareholding Notification	2021-07-13	Swedish
Bulletin from the Saniona AB extraordinary shareholders’ meeting on June 29, 2021 Declaration of Voting Results & Voting Rights Announcements	2021-06-29	English
Kommuniké från extra bolagsstämma den 29 juni 2021 i Saniona AB Declaration of Voting Results & Voting Rights Announcements	2021-06-29	Swedish
Notice of Saniona AB extraordinary shareholders’ meeting Proxy Solicitation & Information Statement	2021-05-26	English
Kallelse till extra bolagsstämma i Saniona AB Proxy Solicitation & Information Statement	2021-05-26	Swedish
Bulletin from the Saniona AB annual shareholders’ meeting on May 26, 2021, and information regarding planned extraordinary shareholders’ meeting Declaration of Voting Results & Voting Rights Announcements	2021-05-26	English
Kommuniké från årsstämma den 26 maj 2021 i Saniona AB samt information om planerad extra bolagsstämma AGM Information	2021-05-26	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report	2021-05-26	Swedish
Interim / Quarterly Report 2021 Interim / Quarterly Report Q1 2021	2021-05-26	English
Major Shareholding Notification 2021 Major Shareholding Notification	2021-05-05	Swedish
Major Shareholding Notification 2021 Major Shareholding Notification	2021-05-05	Swedish
Ändring av antalet aktier och röster i Saniona AB (publ) Share Issue/Capital Change	2021-04-30	Swedish
Change in numbers of shares and votes in Saniona AB (publ) Share Issue/Capital Change	2021-04-30	English
Annual Report 2020 Annual Report FY 2020	2021-04-29	Swedish
Annual Report 2020 Annual Report FY 2020	2021-04-29	English
Notice of Saniona AB annual shareholders’ meeting Proxy Solicitation & Information Statement	2021-04-23	English
Kallelse till årsstämma i Saniona AB Proxy Solicitation & Information Statement	2021-04-23	Swedish
Saniona announces outcome of TO3 warrant exercise Share Issue/Capital Change	2021-04-22	English
Saniona meddelar utfall i inlösen av teckningsoptioner TO 3 Share Issue/Capital Change	2021-04-22	Swedish
Saniona uppdaterar tidsplanerna för den kliniska utvecklingen av Tesomet baserat på besked om tillverkningen från FDA Regulatory Filings	2021-04-22	Swedish
Saniona Updates Tesomet Clinical Development Timelines Based on Manufacturing Feedback from U.S. FDA Regulatory Filings	2021-04-22	English
Saniona meddelar att nyttjandeperioden för teckningsoptioner av serie TO3 inleds den 6 april 2021 Share Issue/Capital Change	2021-03-31	Swedish
Saniona announces that the exercise period of warrants of series TO3 begins on April 6, 2021 Share Issue/Capital Change	2021-03-31	English
Interim / Quarterly Report 2020 Interim / Quarterly Report FY 2020	2021-03-17	Swedish
Annual Report 2020 Annual Report FY 2020	2021-03-17	English
Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Prader-Willi Syndrome Regulatory Filings	2021-03-03	English
Saniona får särläkemedelsklassning av FDA för Tesomet mot Prader-Willis syndrom Regulatory Filings	2021-03-03	Swedish
Saniona postpones 2020 year-end financial report due to restatement and re-audit of prior period financial statements in line with U.S. PCAOB audit standards Report Publication Announcement	2021-02-22	English
Saniona senarelägger publicering av bokslutskommuniké för 2020 till följd av omräkning och förnyad revision av tidigare finansiella rapporter för att uppfylla amerikanska revisionsstandarder Report Publication Announcement	2021-02-22	Swedish